鼻立通膠囊

Land: Taiwan

Språk: kinesiska

Källa: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Aktiva substanser:

PHENYLEPHRINE HCL;;CHLORPHENIRAMINE MALEATE;;PANTOTHENATE CALCIUM;;CALCIUM PHOSPHATE DIBASIC;;THIAMINE MONONITRATE;;RIBOFLAVIN (VIT B2);;NIACINAMIDE (NICOTINAMIDE);;PYRIDOXINE HCL;;NITROFURAZONE;;MAFENIDE (HOMOSULFAMINE);;ALUMINUM HYDROXIDE DRIED GEL

Tillgänglig från:

東化化學藥品股份有限公司 台北巿大同區重慶北路３段１１３巷４３號２Ｆ

Läkemedelsform:

膠囊劑

Sammansättning:

主成分 (EACH CAPSULE CAONTAINS:) ; CHLORPHENIRAMINE MALEATE (0400000810) 0.5MG; PHENYLEPHRINE HCL (1212002310) 5MG; CALCIUM PHOSPHATE DIBASIC (4024000200) 50MG; MAFENIDE (HOMOSULFAMINE) (5204800200) 50MG; ALUMINUM HYDROXIDE DRIED GEL (5604000202) 100MG; NITROFURAZONE (8404602700) 10MG; NIACINAMIDE (NICOTINAMIDE) (8810000300) 5MG; THIAMINE MONONITRATE (8810101001) 1.5MG; RIBOFLAVIN (VIT B2) (8810200400) 0.5MG; PYRIDOXINE HCL (8810600300) 1.5MG; PANTOTHENATE CALCIUM (8812300200) 2.5MG

Enheter i paketet:

瓶裝

Klass:

製　劑

Receptbelagda typ:

須由醫師處方使用

Tillverkad av:

杏輝藥品工業股份有限公司 宜蘭縣冬山鄉中山村中山路８４號 TW

Terapeutiska indikationer:

鼻竇炎、肥厚性鼻炎、過敏性鼻炎

Produktsammanfattning:

註銷日期: 1991/06/12; 註銷理由: 中文品名變更;;英文品名變更;;移轉（申請商）;;移轉（製造廠）; 有效日期: 1991/05/25; 英文品名: PYRITON CAPSULES

Bemyndigande status:

已註銷

Tillstånd datum:

1970-08-20